Chirag Talati, pharma analyst, Espirito Santo Securities says the RBI's move to boost the Indian currency by asking exporters to convert 50% of their foreign exchange holdings into rupees will not have a significant impact on pharma companies.
first published: May 10, 2012 02:56 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

